Friday 6 November 2026 Export ARGX’s income statement to Excel — free account

argenex SE

ARGX Healthcare Biotechnology

argenex SE’s revenue for fiscal 2025 (year ended December 2025) was $4.2 billion, up 88.6% from fiscal 2024.

Revenue: +52.1%
EPS: +43.9%
Free cash flow: +537.5%

Quarter to September 2026, against a year earlier

922.55 27.78 +3.10%

Follow ARGX

Alert me

Market cap: $56.3B
P/E: 29.8×
Fwd P/E: 30.1×
Dividend yield: —
F-score: 5/9
Altman Z: 24.36
Beneish M: −1.51
Dividend safety: n/a

Overview

argenex SE (ARGX) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, argenex SE (ARGX) trades at a P/S ratio of 9.5×. Over the past ten years it has ranged from 0.0× (March 2020) to 185× (February 2021); the current reading is higher than 31% of that period. That is in line with the Biotechnology industry median of 9.2× and above the Healthcare sector median of 3.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ARGX/ps-ratio" width="100%" height="360" style="border:0" loading="lazy" title="argenex SE P/S ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ARGX/metrics/ps-ratio">argenex SE (ARGX) P/S ratio — stockrow.com</a></p>

Period	P/S ratio	Change
FY2025	12.1×	(25.77%)
FY2024	16.3×	(4.80%)
FY2023	17.2×	(62.39%)
FY2022	45.7×	74.60%
FY2021	26.1×	(81.72%)
FY2020	143×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/S ratio	Change
Sep 2026	10.1×	(6.47%)
Jun 2026	10.8×	13.81%
Mar 2026	9.5×	(21.44%)
Dec 2025	12.1×	(1.19%)
25 more quarters	Free account

Against its own ten years

Low 0.0× High 185×

Ten-year median 16.1×

Current reading's percentile 1

Company	P/S ratio
INCY Incyte Corporation compare	4.0×
REGN Regeneron Pharmaceuticals, Inc. compare	5.4×
ONC BeOne Medicines Ltd. - Sponsored ADR compare	6.6×
GMAB Genmab A/S Sponsored ADR compare	7.9×
ARGX argenex SE	9.5×
RPRX Royalty Pharma PLC compare	11.5×
MRNA Moderna, Inc. compare	43.2×
RVMD Revolution Medicines, Inc. compare	185×
ROIV Roivant Sciences Ltd. compare	3,528×
Biotechnology industry median	9.2×
Healthcare sector median	3.5×
Market median	1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

argenex SE (ARGX) P/S ratio

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ARGX

P/S ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/S ratio against peers

What P/S ratio is

More on ARGX

Stockrow Weekly